Haviland Kate (CIK 1663022) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-07-21). Recent activity: Sell BPMC (224,410 shares), Buy BPMC (129,210 shares), Sell BPMC (70,729 shares), Sell BPMC (600 shares), Sell BPMC (598 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-07-21 | Blueprint Medicines Corp (BPMC) | Chief Executive Officer | Sell | 224,410 | $0 |
| 2025-07-21 | Blueprint Medicines Corp (BPMC) | Chief Executive Officer | Buy | 129,210 | $0 |
| 2025-07-21 | Blueprint Medicines Corp (BPMC) | Chief Executive Officer | Sell | 70,729 | $0 |
| 2025-04-03 | Blueprint Medicines Corp (BPMC) | CHIEF EXECUTIVE OFFICER | Sell | 600 | $51,282 |
| 2025-04-03 | Blueprint Medicines Corp (BPMC) | CHIEF EXECUTIVE OFFICER | Sell | 598 | $51,512 |
| 2025-04-03 | Blueprint Medicines Corp (BPMC) | CHIEF EXECUTIVE OFFICER | Sell | 1,200 | $104,808 |
| 2025-04-03 | Blueprint Medicines Corp (BPMC) | CHIEF EXECUTIVE OFFICER | Sell | 100 | $8,859 |
| 2025-03-07 | Blueprint Medicines Corp (BPMC) | CHIEF EXECUTIVE OFFICER | Sell | 16,151 | $1.4M |
| 2025-03-04 | Blueprint Medicines Corp (BPMC) | CHIEF EXECUTIVE OFFICER | Buy | 35,200 | $0 |
| 2025-01-23 | Blueprint Medicines Corp (BPMC) | CHIEF EXECUTIVE OFFICER | Sell | 1,446 | $159,407 |
Source: SEC Form 4 filings · as of 2025-07-21